tiprankstipranks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market

OKYO Pharma Limited Sponsored ADR (OKYO) Financial Statements

Compare
65 Followers

OKYO Pharma Limited Sponsored ADR Financial Overview

OKYO Pharma Limited Sponsored ADR's market cap is currently $35.58M. The company's EPS TTM is $; its P/E ratio is ―; OKYO Pharma Limited Sponsored ADR is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Mar 21Mar 20Mar 19Mar 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income
EBITDA$ -6.22M$ -2.46M$ -1.27M$ -3.76M$ -20.17M
Net Income$ -5.43M$ -2.44M$ -1.21M$ -3.76M$ -20.17M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 3.27M$ 5.16M$ 482.94K$ 582.58K$ 2.01M
Total Debt$ 0.00$ 71.85K$ 25.56K$ 0.00$ 0.00
Net Debt$ 0.00$ -4.94M$ -164.38K$ -481.15K$ -2.01M
Total Liabilities$ 1.03M$ 1.29M$ 595.96K$ 327.16K$ 91.06K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -5.47M-$ -1.07M$ -1.53M$ -53.05M
Operating Cash Flow$ -5.47M$ -1.16M$ -961.17K$ -1.53M$ -1.14M
Investing Cash Flow
Financing Cash Flow
Currency in USD

OKYO Pharma Limited Sponsored ADR Earnings and Revenue History

OKYO Pharma Limited Sponsored ADR Debt to Assets

OKYO Pharma Limited Sponsored ADR Cash Flow

OKYO Pharma Limited Sponsored ADR Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis